Doctors - Clinical Research Informer

Doctors Discover Needle Lodged in 80-Year-Old Woman’s Brain

AuroBlog - Aurous Healthcare Clinical Trials blog

OCTOBER 12, 2023

An elderly woman in Russia’s Far East was revealed on Wednesday to have lived for 80 years with an inch-long needle in her brain, after doctors made the unexpected discovery during a CT scan. Doctors believe the woman was the victim of a failed infanticide carried out by her parents, and said they would not […]

Doctor

Doctor Doctors Clinical Trials Clinical Trials

Should doctors refuse to treat obese patients?

World of DTC Marketing

MARCH 28, 2021

IN BRIEF: Doctors are not required to treat obese patients who won’t do anything to lose weight but the problem is more than reminding patients they need to get exercise and drop pounds. Susan knew she needed to lose weight, especially when her doctor told her that her A1C indicated that she was prediabetic.

Doctor

Doctor Doctors Medicine Production

Even on social media “listen to the doctor”

World of DTC Marketing

JULY 31, 2021

The post Even on social media “listen to the doctor” appeared first on World of DTC Marketing.com. The world of online health-seeking has become more complicated but with some common sense you can find HCPs who know that they are talking about.

Doctor

Doctor Doctors Vaccine Vaccination

After surprise trial failure, ALS doctors brace for one less treatment option

Bio Pharma Dive

MARCH 12, 2024

Physicians are preparing for tough conversations with patients on Amylyx Pharmaceuticals’ drug, Relyvrio, while holding out hope it still may help some with the disease.

Doctor

Doctor Doctors Trials Drugs

Doctors are consumers too! How DTC media impacts HCPs

Bio Pharma Dive

OCTOBER 19, 2020

The findings have implications for how pharma teams should think about their DTC and HCP efforts — they are no longer two separate marketing channels.

Doctor

Doctor Doctors Marketing

Alzheimer’s doctors see promise, limits in Lilly’s latest drug data

Bio Pharma Dive

MAY 10, 2023

While some see the new donanemab results as adding to a “watershed moment” in Alzheimer’s research, others say they reinforce the limitations of so-called anti-amyloid therapies.

Doctor

Doctor Doctors Drugs Research

Teleconsultation positions itself as viable alternative to offset low doctor-to-population ratio & specialists shortage

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 23, 2023

Teleconsultation is seen as a viable alternative with low doctor-to-population ratio and shortage of specialists doctors. In fact, teleconsultation is seen to bridge this gap by allowing patients in remote areas to receive earlier diagnosis and treatment with low cost and faster follow-up check-ups.

Doctor

Doctor Doctors Clinical Trials Clinical Trials

GoodRx launches new push to draw in doctors

Bio Pharma Dive

OCTOBER 13, 2022

Targeting providers directly is a pivot for GoodRx, but the company sees an opportunity to capture more pharmaceutical advertising revenue, said executive Preeti Parikh.

Doctor

Doctor Doctors

Doctor entrepreneurs seek healthcare management expertise to initiate best practices at clinics: Raj Sehgal

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 6, 2023

India’s smart doctor promoters are seeking help of professional healthcare management companies to introduce best healthcare management practices in their establishments, said Raj Sehgal associate director, TR Lifesciences. This is because these clinics encounter challenges even as there are growth prospects.

Doctor

Doctor Doctors Clinical Trials Clinical Trials

For ALS patients, doctors, a new medicine reignites concerns about healthcare access

Bio Pharma Dive

DECEMBER 15, 2022

Relyvrio, a drug developed by Amylyx Pharmaceuticals, is in high demand in ALS clinics across the U.S. Though some patients are already getting it, insurance coverage and out-of-pocket costs remain a source of anxiety.

Doctor

Doctor Doctors Medicine Development

Bluebird's top doctor to depart as company grapples with safety review

Bio Pharma Dive

MARCH 17, 2021

David Davidson has served as Bluebird's chief medical officer since 2012. He'll leave in one month, per a separation agreement with the company.

Doctor

Doctor Doctors

‘Useless’ Organ That Doctors Often Remove May Actually Fight Cancer

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 17, 2023

There’s a small fatty gland that sits behind your sternum and is often said to be ‘useless’ in adulthood.A

Doctor

Doctor Doctors Research Clinical Trials

Diabetes advocacy group discourages use of compounded GLP-1 drugs

Bio Pharma Dive

DECEMBER 2, 2024

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.

Pharmacy

Pharmacy Doctor Doctors Drugs

Vaccine sales driven down by pandemic's effects on doctor visits

Bio Pharma Dive

JULY 31, 2020

Pfizer, Sanofi, GSK and Merck each reported lower vaccine sales as stay-at-home orders kept people from their regular vaccinations.

Sales

Sales Vaccine Vaccination Doctor

ChatGPT outperforms trainee doctors in assessing respiratory illness in children

Pharma Times

SEPTEMBER 9, 2024

Research suggests that LLMs could be used to support trainee doctors, nurses and GPs

Doctor

Doctor Doctors Nurses Research

ICL uses AI to help doctors assess lung cancer from ‘virtual biopsies’

Pharma Times

MARCH 1, 2024

TMR-CT will help doctors select treatment and predict the spread of lung cancer in patients

Doctor

Doctor Doctors

Sage offers details on launch of new postpartum depression pill

Bio Pharma Dive

FEBRUARY 14, 2024

The company and partner Biogen say signs from payers and doctors suggest the launch of Zurzuvae, the first oral therapy for PPD, is off to a good start.

Doctor

Doctor Doctors

As ALS research booms, one treatment center finds itself in the spotlight

Bio Pharma Dive

DECEMBER 20, 2023

The Healey center is at the front of ALS research and care, earning acclaim from patients, doctors and scientists. Still, the complexities of the disease and of drug development have brought hard-felt losses.

Research

Research Doctor Doctors Scientist

Madrigal, FDA approval in hand, outlines plan to sell MASH drug

Bio Pharma Dive

MARCH 15, 2024

The company expects initial uptake of Rezdiffra, which costs $47,400 per year, to be slow as doctors and insurers establish the protocols needed to find patients eligible for treatment.

FDA Approval

FDA Approval Doctor Doctors Drugs

Ten-year survival data show long-term benefit of immunotherapy in melanoma

Bio Pharma Dive

SEPTEMBER 15, 2024

Final follow-up results suggest Opdivo and Yervoy could be close to a cure for some people with advanced melanoma, shifting how doctors administer follow-up care.

Doctor

Doctor Doctors

What to make of Eisai and Biogen’s latest Alzheimer’s drug data

Bio Pharma Dive

NOVEMBER 29, 2022

However, some doctors aren’t yet convinced the medicine’s risks are worth its potential benefits. At a medical conference, the companies detailed clinical trial results that could help support approval of their drug, lecanemab.

Doctor

Doctor Doctors Clinical Trials Clinical Trials

In counties with more Black doctors, Black people live longer, ‘astonishing’ study finds

STAT News

APRIL 14, 2023

The study , published Friday in JAMA Network Open, is the first to link a higher prevalence of Black doctors to longer life expectancy and lower mortality in Black populations.

Doctor

Doctor Doctors Research

ERs staffed by private equity firms aim to cut costs by hiring fewer doctors

NPR Health - Shots

FEBRUARY 11, 2023

One apparent effect: Hiring fewer doctors and more health care practitioners who earn far less. Increasingly, private equity firms shape staffing decisions at hospital emergency rooms, research shows. Image credit: Phil Fisk/Image Source via Getty Images)

Doctor

Doctor Doctors Research

After controversial approval, doctors are still debating how to use Biogen's Alzheimer's drug

Bio Pharma Dive

AUGUST 3, 2021

Nearly two months since Aduhelm became available, many physicians have yet to use the first treatment approved in the U.S. to slow Alzheimer's disease.

Doctor

Doctor Doctors Drugs

Doctor Reveals What Happens When You Stop Taking Ozempic

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 23, 2024

Drugs like Ozempic are very effective at helping most people who take them lose weight. Semaglutide (sold as Wegovy and Ozempic) and tirzepatide (sold as Zepbound and Mounjaro) are the most well known in the class of drugs that mimic hormones to reduce feelings of hunger. But does weight come back when you stop using […]

Doctor

Doctor Doctors Hormones Drugs

Novartis wins FDA approval for new heart drug, but faces uphill sales battle

Bio Pharma Dive

DECEMBER 22, 2021

But uptake could be slow as insurers and doctors weigh the drug's safety and cost-effectiveness. Leqvio, which Novartis acquired for nearly $10 billion two years ago, arrives with high sales expectations.

Sales

Sales FDA Approval Doctor Doctors

UK doctors sceptical of AI's role in treatment

pharmaphorum

SEPTEMBER 11, 2024

One in two UK doctors would not use GenAI to treat patients, but there was more willingness to use it for diagnostic purposes, survey finds

Doctor

Doctor Doctors

Moderna's vaccine can last for weeks in a refrigerator, expanding an edge on rivals

Bio Pharma Dive

NOVEMBER 16, 2020

Pharmacies and doctor's offices should be able to store Moderna's shot on site, a crucial advantage for the mass immunization challenge that lies ahead.

Pharmacy

Pharmacy Doctor Doctors Vaccine

Biogen CEO to step down as company pulls back from Alzheimer's drug

Bio Pharma Dive

MAY 3, 2022

Michel Vounatsos, Biogen's CEO since 2017, will be replaced as the company "substantially" eliminates the commercial workforce around Aduhelm, which has generated paltry sales in the face of resistance from insurers and doctors.

Doctor

Doctor Doctors Sales Drugs

From no drugs to 3: Patients with spinal muscular atrophy now face hard choices

Bio Pharma Dive

OCTOBER 5, 2020

The availability of three vastly different, cutting-edge medicines for the rare disease has put patients, families and doctors in an unfamiliar position.

Doctor

Doctor Doctors Medicine Drugs

Full study data back Alnylam heart drug’s benefit, but leave doctors with tough choices

Bio Pharma Dive

AUGUST 30, 2024

Detailed results from the Helios-B study support summary findings disclosed in June. But they may not make vutrisiran the standard of care as easily as Alnylam hopes.

Doctor

Doctor Doctors

'Dramatic' study results for AstraZeneca, Daiichi drug suggest new way to treat aggressive breast cancer

Bio Pharma Dive

JUNE 5, 2022

A quarter century after Roche's Herceptin became an option for HER2-positive breast cancer, positive study results for Enhertu could push doctors to consider a new classification of "HER2 low" disease.

Doctor

Doctor Doctors Drugs

Obesity drug from Zealand shows potential in early trial

Bio Pharma Dive

JUNE 20, 2024

Interim study data suggest the Danish drugmaker can remain in the race to develop new kinds of weight loss drugs as doctors seek alternatives to the now dominant GLP-1s.

Drugs

Drugs Doctor Doctors Trials

FDA approves AstraZeneca, Daiichi drug in breast cancer first

Bio Pharma Dive

AUGUST 5, 2022

Enhertu is the first targeted treatment cleared for breast cancers that are ‘HER2 low,’ a new classification that could change how doctors treat the disease.

FDA Approval

FDA Approval Doctor Doctors Drugs

King’s Doctoral Training Centre to investigate MS symptom management

Pharma Times

MAY 24, 2024

The lifelong autoimmune disease affects more than 150,000 people living in the UK

Doctor

Doctor Doctors

As Vertex and CRISPR build out Casgevy launch, doctor sees strong demand and warns of possible supply hitches

Fierce Pharma

DECEMBER 21, 2023

As Vertex Pharmaceuticals and CRISPR Therapeutics lay the groundwork for the launch of their CRISPR-based gene-editing therapy Casgevy, one doctor who treats sickle cell disease patients is already | As Vertex Pharmaceuticals and CRISPR Therapeutics lay the groundwork for the launch of their world-first CRISPR-based gene therapy Casgevy, one doctor (..)

Doctor

Doctor Doctors Gene Editing Gene Therapy

Expert Explains Why You Should Clean Your Tongue Twice a Day

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 25, 2024

(Science Photo Library/Getty Images) Has your doctor asked you to stick out your tongue and say “aaah”? The doctor will look for any changes in the tongue’s surface or how it moves. While the GP assesses your throat, they’re also checking out your tongue, which can reveal a lot about your health.

Doctor

Doctor Doctors Clinical Trials Clinical Trials

UniQure offers a closer look at the leading hemophilia B gene therapy

Bio Pharma Dive

DECEMBER 8, 2020

Doctors on Tuesday got a more detailed idea of how the therapy works and who might be eligible to take it, as results from a late-stage trial were presented at ASH.

Gene Therapy

Gene Therapy Gene Doctor Doctors

‘The luckiest of the unlucky’: A Duchenne gene therapy brings hope to families — and tests the FDA

Bio Pharma Dive

MAY 7, 2023

Patient advocates and doctors are anticipating an approval this month of a treatment they believe to be a breakthrough for a deadly disease. But it’s not clear how well the therapy really works, putting the FDA in a difficult position.

Gene Therapy

Gene Therapy Doctor Doctors Gene

Reaching HCPs online

World of DTC Marketing

APRIL 13, 2021

The most desired information doctors now want is about patient assistance programs, with 49% saying they want pharma reps to provide that information. Most doctors sign on in the morning and see a snapshot of what’s happening by their specialty. doctors and 45% of all NPS and physician assistants as verified members.

Doctor

Doctor Doctors Pharma Companies Production

Doctors at Sahyadri Hospitals Pune warn of rising pulmonary embolism cases linked to international travel

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 23, 2024

Over the last two years, Sahyadri Hospitals in Pune has observed a troubling trend of increase in cases of pulmonary embolism (PE) associated with long-haul international travel.

Doctor

Doctor Doctors Clinical Trials Clinical Trials

Biogen's Alzheimer's drug sales remain slow as company warns of further cost cuts

Bio Pharma Dive

FEBRUARY 3, 2022

Aduhelm sales totaled just $1 million in the fourth quarter as Biogen struggles to win over doctors and insurers. The company said it would reduce expenses by more than currently planned if Medicare limits coverage.

Sales

Sales Doctor Doctors Drugs

At ASH, doctors acclaim new sickle cell gene therapies, but are cautious on details

Bio Pharma Dive

DECEMBER 13, 2023

Uptake of Casgevy and Lyfgenia may be slow despite their dramatic benefit, physicians said, citing complexities in treatment, manufacturing and reimbursement.

Gene Therapy

Gene Therapy Doctor Doctors Gene

Govt Siddha doctors in Kerala form new association to promote Siddha dispensaries in rural areas

AuroBlog - Aurous Healthcare Clinical Trials blog

OCTOBER 25, 2022

The Siddha medical practitioners working under the Kerala ISM department and assigned with various Central and state government projects have joined hands to form an organisation of government Siddha medical officers on the lines of the Kerala Government Ayurveda Medical Officers Association.

Doctor

Doctor Doctors Clinical Trials Clinical Trials

Doctors Discover Needle Lodged in 80-Year-Old Woman’s Brain

Should doctors refuse to treat obese patients?

Trending Sources

Even on social media “listen to the doctor”

After surprise trial failure, ALS doctors brace for one less treatment option

Doctors are consumers too! How DTC media impacts HCPs

Alzheimer’s doctors see promise, limits in Lilly’s latest drug data

Teleconsultation positions itself as viable alternative to offset low doctor-to-population ratio & specialists shortage

GoodRx launches new push to draw in doctors

Doctor entrepreneurs seek healthcare management expertise to initiate best practices at clinics: Raj Sehgal

For ALS patients, doctors, a new medicine reignites concerns about healthcare access

Bluebird's top doctor to depart as company grapples with safety review

‘Useless’ Organ That Doctors Often Remove May Actually Fight Cancer

Diabetes advocacy group discourages use of compounded GLP-1 drugs

Vaccine sales driven down by pandemic's effects on doctor visits

ChatGPT outperforms trainee doctors in assessing respiratory illness in children

ICL uses AI to help doctors assess lung cancer from ‘virtual biopsies’

Sage offers details on launch of new postpartum depression pill

As ALS research booms, one treatment center finds itself in the spotlight

Madrigal, FDA approval in hand, outlines plan to sell MASH drug

Ten-year survival data show long-term benefit of immunotherapy in melanoma

What to make of Eisai and Biogen’s latest Alzheimer’s drug data

In counties with more Black doctors, Black people live longer, ‘astonishing’ study finds

ERs staffed by private equity firms aim to cut costs by hiring fewer doctors

After controversial approval, doctors are still debating how to use Biogen's Alzheimer's drug

Doctor Reveals What Happens When You Stop Taking Ozempic

Novartis wins FDA approval for new heart drug, but faces uphill sales battle

UK doctors sceptical of AI's role in treatment

Moderna's vaccine can last for weeks in a refrigerator, expanding an edge on rivals

Biogen CEO to step down as company pulls back from Alzheimer's drug

From no drugs to 3: Patients with spinal muscular atrophy now face hard choices

Full study data back Alnylam heart drug’s benefit, but leave doctors with tough choices

'Dramatic' study results for AstraZeneca, Daiichi drug suggest new way to treat aggressive breast cancer

Obesity drug from Zealand shows potential in early trial

FDA approves AstraZeneca, Daiichi drug in breast cancer first

King’s Doctoral Training Centre to investigate MS symptom management

As Vertex and CRISPR build out Casgevy launch, doctor sees strong demand and warns of possible supply hitches

Expert Explains Why You Should Clean Your Tongue Twice a Day

UniQure offers a closer look at the leading hemophilia B gene therapy

‘The luckiest of the unlucky’: A Duchenne gene therapy brings hope to families — and tests the FDA

Reaching HCPs online

Doctors at Sahyadri Hospitals Pune warn of rising pulmonary embolism cases linked to international travel

Biogen's Alzheimer's drug sales remain slow as company warns of further cost cuts

At ASH, doctors acclaim new sickle cell gene therapies, but are cautious on details

Govt Siddha doctors in Kerala form new association to promote Siddha dispensaries in rural areas

Stay Connected